The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Not on about making any rip off copies or patients… It was a casual comment on the difficulties of entering a market (like with any product) through sourcing the best distribution channel. An established competing player that has inside links to the government pharmacy industry will obviously wish to maintain their market share - some will do whatever they can. I’m not referring to the whole world, I was picking up on parts of Asia. Look it really doesn’t matter, it was just a personal observation. A response to a comment- not negative against STX.
I agree, also believe this is just the tip of the iceberg. However, after spending the last 20 years working in foreign lands you may have the best product in the world but local corruption is rife, particularly in some of the regions you mention. Sadly its still easy for a competing company / distributor with the worst / not so good product to gain / maintain a majority market share if they ‘know’ or are friendly with the right contacts….
Frustrating when cash is tied up in other risks…. Reminds me of having to choose which slot or poker table to play on when I was on hol in Vegas - apart from always leaving broke ??
I’m just waiting a bit longer before another big buy… lower the better for me :-))
So, great results and a better name being proposed that better reflects its customer base and direction… 8% drop… we’ll I’m here for the long haul. They can call it ‘Avon bananas’ if they wish. Great company!
Think people have a significantly higher chance of being run over by a NEX bus than getting a blood clot....
I wouldn’t have expected so many sales the eve before results... but, good opportunity to buy more IF it falls....
...nice encouragement from recent trades? I’m no expert, far from it... I’m just a tadpole in a big pond compared to you guys :-)
I’m in two minds in whether to cash in my FSSA Japan focus containing some severely overvalued stock such as GMO Payment, Keyence etc and adding it to my existing GSK stock. I’m not adverse to risk.... I have confidence in GSK. Only been trading for a couple of years and still learning... despite the collapse in 2020 I’ve been fortunate to still have total 30% gain... more luck / gamble than skill. ...
I’m just starting out on investing and prob don’t know a fraction of what you guys know. Silly question... I’ve just been looking at the daily trades, and someone has sold over 600£k of shares at closing... this is a lot more than those buying.... is that normal? Is that sign that the price will dip tomorrow?
Hopefully the it will bring the price up to 182 :-)
https://www.nationalexpressgroup.com/newsmedia/news-across-the-group/2020/shes-electric-national-express-launches-zero-emission-future/
https://www.nationalexpressgroup.com/newsmedia/news-across-the-group/2020/national-express-announces-new-coach-business/
Not sure why NEX isn't issuing a statement..